Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Conference Coverage

Hilary Baldwin
Conference Coverage
Acne: Challenging Cases
09/18/2022
Riya Gandhi, MA, Associate Editor
Hilary Baldwin, MD, presented the session “Challenging Acne Cases,” on the last day of Fall Dermatology Week 2022.
Hilary Baldwin, MD, presented the session “Challenging Acne Cases,” on the last day of Fall Dermatology Week 2022.
Hilary Baldwin, MD, presented...
09/18/2022
The Dermatologist
Ruth Ann Vleugels, MD, MPH, MBA
Conference Coverage
Janus Kinase Inhibitors in Dermatology
09/17/2022
Coleen Stern, MA, Senior Managing Editor
In her session, “JAKs in Dermatology,“ presented at Fall Dermatology Week 2022, Ruth Ann Vleugels, MD, MPH, MBA, offered pearls for integrating Janus kinase (JAK) inhibitors into patient care.
In her session, “JAKs in Dermatology,“ presented at Fall Dermatology Week 2022, Ruth Ann Vleugels, MD, MPH, MBA, offered pearls for integrating Janus kinase (JAK) inhibitors into patient care.
In her session, “JAKs in...
09/17/2022
The Dermatologist
Henry W. Lim, MD
Conference Coverage
Insights Into Photdermatoses: Diagnosis and Treatment Updates
09/17/2022
Jessica Garlewicz, Associate Digital Editor
During his session, “Photodermatoses: Diagnosis and Management,” Henry W. Lim, MD, presented the various dermatoses, and how to recognize important and new developments in photodermatoses.
During his session, “Photodermatoses: Diagnosis and Management,” Henry W. Lim, MD, presented the various dermatoses, and how to recognize important and new developments in photodermatoses.
During his session,...
09/17/2022
The Dermatologist

Advertisement

Harper Julie
Conference Coverage
Diagnosis and Treatment of Rosacea
09/16/2022
Riya Gandhi, MA, Associate Editor
In her session, “Rosacea: Diagnosis and Treatment,” presented at Fall Dermatology Week 2022, Julie Harper, MD, reviewed the new diagnostic classification of rosacea, pathogenesis of rosacea, and treatment strategies.
In her session, “Rosacea: Diagnosis and Treatment,” presented at Fall Dermatology Week 2022, Julie Harper, MD, reviewed the new diagnostic classification of rosacea, pathogenesis of rosacea, and treatment strategies.
In her session, “Rosacea:...
09/16/2022
The Dermatologist
Stein Gold L
Conference Coverage
What Is Up and Coming in Rosacea?
09/16/2022
Riya Gandhi, MA, Associate Editor
In her session, “Rosacea: What’s New and What’s Coming,” presented at Fall Dermatology Week 2022, Linda Stein Gold, MD, discussed the pathogenesis, novel topical treatment options, and systemic approaches to rosacea.
In her session, “Rosacea: What’s New and What’s Coming,” presented at Fall Dermatology Week 2022, Linda Stein Gold, MD, discussed the pathogenesis, novel topical treatment options, and systemic approaches to rosacea.
In her session, “Rosacea: What’s...
09/16/2022
The Dermatologist
Mark Lebwohl
Conference Coverage
Actinic Keratoses: New Approaches to Treatment
09/16/2022
Riya Gandhi, MA, Associate Editor
Mark Lebwohl, MD, presented the session “Actinic Keratosis: Optimizing the Use of Topical Treatment Options in Clinical Practice” on the second day of Fall Dermatology Week 2022.
Mark Lebwohl, MD, presented the session “Actinic Keratosis: Optimizing the Use of Topical Treatment Options in Clinical Practice” on the second day of Fall Dermatology Week 2022.
Mark Lebwohl, MD, presented the...
09/16/2022
The Dermatologist

Advertisement

Heidi B. Prather, MD
Conference Coverage
Cosmetic Surgeries: Patient Psychosocial and Quality of Life impact
09/16/2022
Jessica Garlewicz, Associate Digital Editor
During her session, “Cosmetic Surgery and its Impact on Quality of Life,” Heidi B. Prather, MD, FAAD, opened with the psychosocial and quality of life impacts commonly seen in cosmetic dermatology.
During her session, “Cosmetic Surgery and its Impact on Quality of Life,” Heidi B. Prather, MD, FAAD, opened with the psychosocial and quality of life impacts commonly seen in cosmetic dermatology.
During her session, “Cosmetic...
09/16/2022
The Dermatologist
Vincent Richer, MD, FRCPC
Conference Coverage
Redness and Pigment in Skin of Color: Insights Into Laser Surgery
09/16/2022
Jessica Garlewicz, Associate Digital Editor
During his presentation, “Laser Surgery: What You Need to Know,” at Fall Dermatology Week 2022, Vincent Richer, MD, FRCPC, discussed treating redness, pigment in skin of color, resurfacing, and choosing the best laser devices.
During his presentation, “Laser Surgery: What You Need to Know,” at Fall Dermatology Week 2022, Vincent Richer, MD, FRCPC, discussed treating redness, pigment in skin of color, resurfacing, and choosing the best laser devices.
During his presentation, “Laser...
09/16/2022
The Dermatologist
Brett King, MD, Phd
Conference Coverage
Clinical Challenges and Emerging Treatments in Alopecia Areata
09/15/2022
Coleen Stern, MA, Senior Managing Editor
In his session, “Alopecia Areata: Clinical Challenges and Emerging Treatments,” on the second day of Fall Dermatology Week 2022, Brett King, MD, PhD, discussed the unmet need for effective treatments.
In his session, “Alopecia Areata: Clinical Challenges and Emerging Treatments,” on the second day of Fall Dermatology Week 2022, Brett King, MD, PhD, discussed the unmet need for effective treatments.
In his session, “Alopecia...
09/15/2022
The Dermatologist

Advertisement

Howard Steinman, MD
Conference Coverage
Mohs Micrographic Surgery: Principals and Benefits
09/15/2022
Jessica Garlewicz, Associate Digital Editor
At the start of his session, “Understanding Mohs Surgery and Its Indications,” presented at Fall Dermatology Week 2022, Howard Steinman, MD, discussed the principles of Mohs micrographic surgery.
At the start of his session, “Understanding Mohs Surgery and Its Indications,” presented at Fall Dermatology Week 2022, Howard Steinman, MD, discussed the principles of Mohs micrographic surgery.
At the start of his session,...
09/15/2022
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Current Issue

August 2024
Volume 32
Issue 5
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Popular Articles

Positive Phase III Data for Advanced Melanoma Treatment
10/20/2014
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from CheckMate-037, a Phase III, randomized, controlled, open-label study of nivolumab (Opdivo, Bristol-Myers Squibb), versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously...
Positive results from...
10/20/2014
The Dermatologist
Chief Medical Editor Message
Navigating the Turbulent Health Care System
04/18/2017
Steve R. Feldman, MD, PhD
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party payment has, for many years, struck me as fundamentally flawed.
Our system of third-party...
04/18/2017
The Dermatologist
The Relevance of Vehicle in Low-Potency Topical Steroids: 2 Case Studies of Pruritic Condition
07/25/2014
07/25/2014
The Dermatologist
News
Psoriasis Treatment Improves Skin Clearance in Biologic Naïve Patients
03/14/2017
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque psoriasis, who were naïve to systemic biologic therapy, showed significantly improved skin clearance when treated with the oral, selective inhibitor of phosphodiesterase 4 apremilast (Otezla; Celgene Corp),...
Patients with moderate plaque...
03/14/2017
The Dermatologist
New Topical Onychomycosis Treatment Approved
06/13/2014
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical solution (Jublia, Valeant Pharmaceuticals North America LLC, received approval as the first topical triazole approved for the treatment of onychomycosis of the toenails. The licensor and business partner for...
Efinaconazole 10% topical...
06/13/2014
The Dermatologist

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

The Dermatologist Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Latest Quizzes and Trivia

Quiz
QUIZ: Topical PDE-4 Inhibitors For Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis
08/10/2024
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola emphasize for atopic dermatitis?
What strategies did Dr Merola...
08/10/2024
The Dermatologist
contact dermtitis + Neck + Eczema + rash
Quiz
QUIZ: Patient Experiences in Contact Dermatitis and Patch Testing
07/14/2024
What is a common challenge for patients during the patch testing week?
What is a common challenge for patients during the patch testing week?
What is a common challenge for...
07/14/2024
The Dermatologist
gloves hands
Quiz
Quiz: Barrier to Mental Health Support in Patients with Atopic Dermatitis
05/30/2024
Riya Gandhi, MA, Associate Editor
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview with Jessica Johnson, MPH, what is a significant barrier to seeking mental health support among patients with atopic dermatitis?
According to a recent interview...
05/30/2024
The Dermatologist
Atopic dermatitis
Quiz
Quiz: Atopic Dermatitis Spotlight
05/06/2024
Riya Gandhi, MA, Associate Editor
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications received a "general thumbs up" in the latest guidelines for atopic dermatitis management due to their efficacy and low cancer risk?
Which class of medications...
05/06/2024
The Dermatologist
basal cell carcinoma
Quiz
True or False: Basal Cell Carcinoma on Vermilion Lip
05/01/2024
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the vermilion lip a distinctly rare phenomenon, sparsely documented in existing literature?
Is basal cell carcinoma on the...
05/01/2024
The Dermatologist
Atopic Dermatitis + Eczema + Itch + Rash + Kids + Legs + Elbow + Knee
Quiz
Quiz: Navigating New Therapies in Atopic Dermatitis
04/10/2024
Riya Gandhi, MA, Associate Editor
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr Jonathan Silverberg, mentioned the importance of understanding the strengths and weaknesses of new therapies. Which aspect did he particularly emphasize as crucial in clinical practice?
In a recent interview, Dr...
04/10/2024
The Dermatologist
AD
Quiz
Trivia: Atopic Dermatitis Patients With Alopecia Areata
02/28/2024
Riya Gandhi, MA, Associate Editor
02/28/2024
The Dermatologist
AD
Quiz
Trivia: Itch Cycle and OTC Products
12/27/2023
12/27/2023
The Dermatologist
psoriasis
Quiz
Trivia: Recommended Treatment For Psoriasis
12/20/2023
Jessica Garlewicz, Digital Managing Editor
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate and moderate to severe plaque psoriasis, what is the recommended treatment?
When treating mild to moderate...
12/20/2023
The Dermatologist
Ilka Arun Netravali, MD, PhD, FAAD
Quiz
Dupilumab Mechanism of Action
11/07/2023
Jessica Garlewicz, Digital Managing Editor
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview with Dr Ilka Arun Netravali, what is the mechanism of action behind dupilumab that translates to effective suppression of atopic disease?
According to a recent interview...
11/07/2023
The Dermatologist

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use